All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate Bonds

BioMérieux debuts unrated at tight spread

BioMérieux, the French medical diagnostics company, sold its first bond on Monday to a warm reception that showed just how tightly unrated companies can price.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree